Hepatitis C Remedy Choices



Ryan Ford, MD, assistant professor of drugs, Division of Digestive Ailments, Emory College College of Medication.

William D. Carey, MD, senior hepatologist, Division of Gastroenterology, Cleveland Clinic, Cleveland, Ohio.

HCV Advocate: “A Transient Historical past of Hepatitis C.”

CDC: “Hepatitis C FAQs for Customers.”

Curry, M.P. New England Journal of Medication, Dec. 31, 2015.

FDA: “FDA Drug Security Communication: FDA warns of great liver damage danger with hepatitis C therapies Viekira Pak and Technivie,” “FDA approves Viekira Pak to deal with hepatitis C,”  “Drug Trials Snapshots: VOSEVI,” “FDA approves Epclusa for remedy of power Hepatitis C virus an infection.”

Feld, J. NEJM, Nov. 23, 2015.

HCV Advocate. “What’s Cirrhosis?”

HCV New Drug Analysis: “ZEPATIER – Really helpful Dosage and Durations, Drug Interactions, Aspect Results, Medical Research.”

Information Launch, Gilead.

Information Launch, Merck.

Up-To-Date: “Direct-acting antivirals for the remedy of hepatitis C virus an infection.”

U.S. Division of Veterans Affairs: “Hepatitis C Virus Genotypes and Quasispecies.”

College of Washington: “Sofosbuvir (Sovaldi).”

Zeuzem, S. Annals of Inner Medication, July 7, 2015.

Leave a Comment

× WhatsApp